ArticleMedical journal, Armed Forces India
Estimation of fetomaternal haemorrhage using flow cytometry in antenatal care patients at an tertiary care hospital in Western Maharashtra.
Article in Medical journal, Armed Forces India. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Fetomaternal haemorrhage (FMH), in which foetal red blood cells enter maternal circulation, can cause complications like foetal anaemia, hydrops foetalis, alloimmunisation and foetal death. A notable gap exists in the literature regarding FMH quantification in the Indian patient population vis-a-vis the Western population. This study estimated severe FMH using flow cytometry (FCM) in antenatal patients at a tertiary care hospital in Western Maharashtra. Methods: This single-centre, prospective observational study was conducted over two years in our institute on 100 consenting antenatal patients. Venous blood samples were analysed with dual-colour FCM to quantify foetal red blood cells, and FMH volume was calculated. Results: Among the 100 antenatal patients, 54% were primigravida with a mean age of 25.68 years. Severe FMH (>30 ml) was detected in 40% of participants using FCM. Most mothers (94%) and newborns (97%) were RhD positive, with no active alloimmunisation cases. Statistical analysis showed no significant links between FMH and maternal age, blood group, parity, delivery type, haemoglobin levels, gestational age, or newborn gender, except for a significant (p = 0.032) association with Rh status. Conclusion: Presence of severe FMH in up to 40% of our study population indicates that severe FMH in present Indian subset of antenatal care (ANC) clientele is a considerable phenomenon and underscores the need to conduct research in Indian population in this direction.Similarly, the modality for FCM for FMH evaluation in Indian patient clientele should be considered to all the high-risk ANC where severe FMH is expected.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.